Insulin sensitivity independently influences brachial-ankle pulse-wave velocity in non-diabetic subjects

Diabetic Medicine

Volumn 22, Issue 12, 2005, Pages 1701-1706

  Kasayama, Soji ^a   Saito, H ^b   Mukai, M ^b   Koga, M ^b  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Kinki Central Hospital of Mutual Association of Public School Teachers   (Japan)

Author keywords

Atherosclerosis; Inflammation; Insulin resistance; Pulse wave analysis

Indexed keywords

C REACTIVE PROTEIN; CREATININE; GLUCOSE; INSULIN; TRIACYLGLYCEROL;

ADULT; AGED; ANKLE BRACHIAL INDEX; ARTERY INTIMA PROLIFERATION; ARTICLE; B SCAN; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CREATININE BLOOD LEVEL; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIVER FUNCTION TEST; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NON INVASIVE MEASUREMENT; ORAL GLUCOSE TOLERANCE TEST; PERIODIC MEDICAL EXAMINATION; PROTEIN BLOOD LEVEL; PULSE WAVE; RISK FACTOR; SAMPLE SIZE; SYSTOLIC BLOOD PRESSURE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ANKLE; BLOOD FLOW VELOCITY; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CHOLESTEROL; FEMALE; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; JAPAN; MALE; MIDDLE AGED; PULSE; REGRESSION ANALYSIS; SEX DISTRIBUTION;

EID: 30044436747     PISSN: 07423071     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1464-5491.2005.01718.x     Document Type: Article

References (28)

1. Howard G, O'Leary DH, Zaccaro D, Haffner S, Rewers M, Hamman R et al. Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996; 93: 1809-1817.
2. Yip J, Facchini FS, Reaven GM. Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. J Clin Endocrinol Metab 1998; 83: 2773-2776.
3. DeFronzo RA, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991; 14: 173-194.
4. Ginsberg HN. Insulin resistance and cardiovascular diseases. J Clin Invest 2000; 106: 453-458.
5. Wilkinson IB, Webb DJ, Cockcroft JR. Aortic pulse-wave velocity. Lancet 1999; 354: 1996-1997.
6. Taniwaki H, Kawagishi T, Emoto M, Shoji T, Kanda H, Maekawa K et al. Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes. Diabetes Care 1999; 22: 1851-1857.
7. van Popele NM, Grobbee DE, Bots ML, Asmar R, Topouchian J, Reneman RS, et al. Association between arterial stiffness and atherosclerosis: the Rotterdam Study. Stroke 2001; 32: 454-460.
8. Blacher J, Asmar R, Djane S, London GM, Safar ME. Aortic pulse wave velocity as a marker of cardiovascular risk in hypertensive patients. Hypertension 1999; 33: 1111-1117.
9. Suzuki E, Kashiwagi A, Nishio Y, Egawa K, Shimizu S, Maegawa H et al. Increased arterial wall stiffness limits flow volume in the lower extremities in type 2 diabetic patients. Diabetes Care 2001; 24: 2107-2114.
10. Kubo T, Miyata M, Minagoe S, Setoyama S, Maruyama I, Tei C. A simple oscillometric technique for determining new indices of arterial distensibility. Hypertens Res 2002; 25: 351-358.
11. Yamashina A, Tomiyama H, Takeda K, Tsuda H, Arai T, Hirose K, Koji Y et al. Validity, reproducibility, and clinical significance of noninvasive brachial-ankle pulse wave velocity measurement. Hypertens Res 2002; 25: 359-364.
12. Tomiyama H, Yamashina A, Arai T, Hirose K, Koji Y, Chikamori T et al. Influences of age and gender on results of non-invasive brachial-ankle pulse wave velocity measurement-a survey of 12 517 subjects. Atherosclerosis 2003; 166: 303-309.
13. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985; 28: 412-419.
14. The DECODE Study Group on behalf of the European Diabetes Etiology Group. Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE Study Group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis of Diagnostic criteria in Europe. Lancet 1999; 354: 617-621.
15. 1c level. Diabetes Care 2000; 23: 1830-1834.
16. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. Br Med J 1996; 312: 1061-1065.
17. Alberti KGMM, Zimmet PZ for the WHO Consultation. Definition, diagnosis and classification of diabetes, mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553.
18. Bortolotto LA, Blacher J, Kondo T, Takazawa K, Safar ME. Assessment of vascular aging and atherosclerosis in hypertensive subjects: second derivative of photoplethysmogram versus pulse wave velocity. Am J Hypertens 2000; 13: 165-171.
19. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972; 18: 499-502.
20. Hata Y, Mabuchi H, Saito Y, Itakura H, Egusa G, Ito H et al., Working Committee on JAS. Guideline for diagnosis and treatment of hyperlipidemias. J Atheroscler Thromb 2002; 9: 1-27.
21. Hashimoto K, Kasayama S, Yamamoto H, Kurebayashi S, Kawase I, Koga M. Strong association of C-reactive protein with body mass index and 2-h post-challenge glucose in non-diabetic, non-smoker subjects without hypertension. Diabet Med 2004; 21: 581-585.
22. Levy JC, Matthews DR, Hermans MP. Correct homeostasis model assessment (HOMA) evaluation uses the computer program. Diabetes Care 1998; 21: 2191-2192.
23. Rajala U, Laakso M, Paivansalo M, Pelkonen O, Suramo I, Keinanen-Kiukaanniemi S. Low insulin sensitivity measured by both quantitative insulin sensitivity check index and homeostasis model assessment method as a risk factor of increased intima-media thickness of the carotid artery. J Clin Endocrinol Metab 2002; 87: 5092-5097.
24. Emoto M, Nishizawa Y, Kawagishi T, Maekawa K, Hiura Y, Kanda H et al. Stiffness indexes β of the common carotid and femoral arteries are associated with insulin resistance in NIDDM. Diabetes Care 1998; 21: 1178-1182.
25. Satoh N, Ogawa Y, Usui T, Tagami T, Kono S, Uesugi H et al. Anti-atherogenic effect of pioglitazone in type 2 diabetic patients irrespective of the responsiveness to its anti-diabetic effect. Diabetes Care 2003; 26: 2493-2499.
26. Minamikawa J, Tanaka S, Yamauchi M, Inoue D, Koshiyama H. Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 1998; 83: 1818-1820.
27. Hsueh WA, Lyon CJ, Quinones MJ. Insulin resistance and the endothelium. Am J Med 2004; 117: 109-117.
28. Cheung YF, Chan GC, Ha SY. Arterial stiffness and endothelial function in patients with β-thalassemia major. Circulation 2002; 106: 2561-2566.